Eleven Therapeutics
Tel Aviv
About Eleven Therapeutics
Eleven Therapeutics is a biotechnology company at the forefront of the artificial intelligence revolution in medicinal nucleic acids. The new generation of RNAi therapies is introduced by merging artificial intelligence, parallel functional testing, and combinatorial chemistry. SCSI-RNA is a programmable molecule that can be used to target any disease or biological target of interest.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $26.3M
- Funding stage: Seed
- Last round: Seed (Aug 2022)
- Website: eleventx.com
Industries & Categories
Biotechnology, Medical, Product Research, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/eleven-therapeutics-68975 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.